GE HealthCare Technologies Inc. Common Stock (GEHC) Financials
Key financial figures for GE HealthCare Technologies Inc. Common Stock (Q3 2026).
GE HealthCare Q3 2026 revenue rose 7.2% to $5,513 million (6.2% organic) with Adjusted EPS of $1.34 versus $1.07, and the company raised full-year 2026 guidance. Revenue was $5,513 million, up 7.2% year over year (organic +6.2%), with growth in all three segments. Organic orders rose 4.0%, book-to-bill was 1.03 times and backlog was $23.7 billion. The release says results were ahead of company expectations; no analyst consensus figure is cited here. Profitability: GAAP diluted EPS was $1.36 versus $0.98 (up 39.1%) and Adjusted EPS was $1.34 versus $1.07 (up 25.1%). On the outlook: Full-year 2026 guidance raised: organic revenue growth about 4.0% (previously 3.0% to 4.0%), Adjusted EBIT margin 15.5% to 15.7% (previously 15.4% to 15.7%), Adjusted EPS $4.95 to $5.05 (previously $4.80 to $5.00), free cash flow $1.6 billion or more (previously about $1.6 billion); Adjusted effective tax rate reaffirmed at 20.0% to 21.0%. Figures are for Q3 2026, as GE HealthCare Technologies Inc. reported them.
- Revenue
- $5.5B
- Net Income
- $614M
- EPS
- $1.36
- Total Assets
- $38.4B
- Operating Cash Flow
- $907M
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q3 FY2026 | $5.5B | $614M | $1.36 | 14.58% | $793M |
| Q2 FY2026 | $5.3B | $573M | $1.24 | 13.96% | -$617M |
| Q1 FY2026 | $5.1B | $389M | $0.85 | 10.04% | $112M |
| Q4 FY2025 | $4.7B | $184M | $0.38 | 14.21% | $917M |
| Q3 FY2025 | $5.1B | $446M | $0.98 | 12.7% | $483M |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | $20.6B | $2.1B | $4.55 | 13.39% | $1.5B |
| FY2024 | $19.7B | $2.0B | $4.34 | 13.34% | $1.6B |
| FY2023 | $19.6B | $1.6B | $3.03 | 12.45% | $1.7B |
Frequently asked questions
What was GE HealthCare Technologies Inc.'s revenue last quarter?
GE HealthCare Technologies Inc. reported revenue of $5.51 billion for Q3 FY2026, up 7.2% from the same period a year earlier.
Is GE HealthCare Technologies Inc. profitable?
Yes. GE HealthCare Technologies Inc. reported net income of $614.0 million for Q3 FY2026, a net margin of 11.14% on revenue.
How has GE HealthCare Technologies Inc.'s margin trended?
Operating margin was 14.58% in Q3 FY2026, compared with 12.7% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.
How much free cash flow did GE HealthCare Technologies Inc. generate?
GE HealthCare Technologies Inc. generated free cash flow of $793.0 million in Q3 FY2026, after capital expenditure.
Full income statement, balance sheet and cash flow for GE HealthCare Technologies Inc. Common Stock on SentiSense, with up to forty quarters and twenty fiscal years of history.